Data ownership from implantable bioelectronic devices

Introduction

Implantable bioelectronic devices are medical technologies placed inside the human body to monitor, stimulate or regulate biological functions. Examples include cardiac pacemakers, cochlear implants, deep brain stimulation devices, neural recording implants and implantable glucose monitors. These devices generate valuable information concerning an individual's physiological condition, medical history and biological activities.

The data produced by these devices can be used for medical diagnosis, treatment adjustment, scientific research, artificial intelligence development and commercial innovation. However, determining who owns this information creates important legal questions. Patients, device manufacturers, hospitals, software developers and research institutions may all have different interests in the same dataset.

Data ownership from implantable bioelectronic devices therefore involves privacy rights, intellectual property, informed consent, contractual rights, medical confidentiality and regulatory responsibilities.

Legal distinction between data ownership and privacy rights

One of the main legal difficulties is that ownership of a medical device does not automatically establish ownership of all information generated by it.

For example, a patient may own or legally possess an implanted cardiac device, while the manufacturer operates the software infrastructure through which device information is transmitted. Similarly, hospitals may maintain medical records containing information generated by the device.

It is necessary to distinguish between:

Patient rights: Individuals have privacy and informational interests in personal health information.

Manufacturer rights: Companies may own proprietary software, device technology and certain database structures.

Hospital rights: Healthcare institutions may maintain and control medical records under applicable legal and professional requirements.

Research rights: Researchers may obtain permission to analyse device-generated information for approved scientific purposes.

Contractual rights: Agreements may determine access, licensing, storage and permitted commercial use.

Importantly, the legal right to control or access personal information is not always equivalent to property ownership over the underlying dataset.

Indian legal and regulatory framework

1. Constitutional right to privacy

Article 21 of the Constitution of India protects the right to life and personal liberty. In K.S. Puttaswamy v. Union of India (2017), the Supreme Court recognised privacy as a fundamental right, including informational privacy.

This principle is important because implantable bioelectronic devices may continuously generate information about a patient's heart activity, neurological condition, glucose levels and other physiological functions. Such information should not be collected, disclosed or commercially exploited without an appropriate legal basis.

2. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 regulates digital personal data processing within its scope. Device-generated information that identifies or relates to an individual may qualify as personal data.

Healthcare providers and device manufacturers must examine their obligations concerning lawful processing, security safeguards and individual rights, depending on their roles and the Act's applicable commencement provisions.

The Act does not create a general property ownership right over personal data. Instead, it establishes a framework governing the processing of digital personal data.

3. Medical confidentiality and professional responsibilities

Healthcare professionals are required to protect patient confidentiality under applicable medical ethics and professional standards. Information generated through implanted devices may form part of a patient's medical record.

Hospitals should therefore establish procedures governing access, disclosure, retention and sharing of device-generated information.

4. Medical device regulation

The Medical Devices Rules, 2017, under the Drugs and Cosmetics Act, 1940, regulate medical devices in India. Implantable bioelectronic products may fall within the applicable classification and regulatory requirements.

Manufacturers must also consider product safety, performance, quality management and post-market monitoring obligations. Where devices transmit patient information, cybersecurity and privacy safeguards become important aspects of responsible product design.

Ownership and commercial use of device-generated data

Manufacturers may use device-generated information to improve device performance, identify technical problems and develop new products. However, commercial interests do not automatically provide unrestricted authority to use identifiable patient information.

A legally appropriate agreement should explain:

Who can access the information generated by the device.

Whether information may be transferred to cloud servers.

Whether manufacturers can use data for product improvement.

Whether research institutions can access the information.

Whether anonymised datasets may be commercially licensed.

How patients can exercise applicable privacy rights.

What happens to stored information when a device is replaced or a patient changes healthcare providers.

Particular care is necessary when information is used to train artificial intelligence systems. Consent and other applicable legal requirements should be examined before identifiable health information is reused for unrelated purposes.

Case laws

1. K.S. Puttaswamy v. Union of India (2017)

The Supreme Court recognised privacy as a fundamental right under Article 21. The judgment established important principles concerning informational privacy, autonomy and proportionality. These principles support the protection of information generated by implantable bioelectronic devices.

2. District Registrar and Collector v. Canara Bank (2005)

The Supreme Court recognised the importance of privacy and confidentiality in personal records. Its reasoning is relevant by analogy to electronic medical records and information generated by implanted devices, particularly where third parties seek access to confidential information.

3. Samira Kohli v. Dr. Prabha Manchanda (2008)

The Supreme Court emphasised that valid medical consent must be informed and voluntary. Its principles are relevant when patients agree to the collection, storage or secondary use of information generated by implantable medical devices. Consent for treatment should not automatically be treated as consent for unrelated commercial data processing.

4. Moore v. Regents of the University of California (1990)

The California Supreme Court considered whether a patient could claim property rights over cells removed during medical treatment and subsequently used for commercial research. The court rejected the conversion claim over the excised cells but recognised potential liability arising from a physician's failure to disclose relevant financial interests.

Although the case concerned biological samples rather than electronic device data, it provides useful comparative guidance on the distinction between personal interests, biological materials and commercial research rights.

5. Carpenter v. United States (2018)

The United States Supreme Court held that government access to historical cell-site location information generally required a warrant. Although the case concerned mobile phone location records, it illustrates the privacy concerns associated with continuously generated personal information. Similar concerns may arise from continuous monitoring through implanted bioelectronic devices.

Legal challenges and responsibilities

Several challenges remain in determining the rights associated with implantable device information. These include disagreements over database control, commercial licensing, access after device replacement, cybersecurity incidents and the use of patient information for artificial intelligence research.

Manufacturers and healthcare institutions should adopt clear data governance policies. These should include encryption, access controls, transparent privacy notices, data-sharing agreements, retention policies and procedures for reporting security incidents.

Patients should also receive understandable information about what their devices record, where information is stored, who can access it and how it may be used.

Conclusion

Data ownership from implantable bioelectronic devices is a developing area of healthcare and technology law. Although manufacturers, hospitals and researchers may possess contractual or intellectual property interests in device-generated datasets, these interests do not eliminate patients' privacy and confidentiality rights. Indian constitutional principles, data protection legislation and medical device regulations provide an important foundation for responsible data governance. Decisions such as Puttaswamy, Samira Kohli and Moore offer useful legal guidance. A balanced framework must protect patient autonomy while allowing legitimate medical research, technological development and commercial innovation.